A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

NCT06882746 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Carcinoma
Gastric Carcinoma
Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: BI 765049

Sponsor

Boehringer Ingelheim